Growth investors picking a large-cap vehicle in 2026 face a real choice: pay nothing for a passive index, or pay a few basis points for an active manager who claims to add value. The Fidelity Enhanced Large Cap Growth ETF (NYSEARCA:FELG) sits squarely in that second camp, charging 0.18% for an actively managed take on the Russell 1000 Growth universe. The pitch is straightforward: index-like cost, with quantitative tilts intended to beat the benchmark over time.
Whether that pitch holds up depends on what an investor is actually buying, and what they could have owned instead.
The Job FELG Is Hired To Do
FELG is built to fill the large-cap growth sleeve of a portfolio. That is the slice meant to capture the earnings power of America’s biggest secular winners: the megacap technology platforms, the AI infrastructure complex, and a handful of healthcare and consumer names riding durable demand curves. The return engine is straightforward equity ownership, not options income or leverage. Investors get paid when underlying companies grow earnings and the market rerates them higher.
The “enhanced” label means Fidelity’s quant team adjusts weights around the index using factor signals, looking to add a modest spread above the Russell 1000 Growth benchmark while keeping tracking error contained. It is closet-active rather than concentrated stock-picking.
The portfolio reflects exactly what you would expect. NVIDIA sits at roughly 13% of net assets, Apple at about 12%, and Microsoft at 10%. Those three names alone account for 34.27% of the fund.
Round out the top ten with Broadcom near 5%, Amazon and Meta around 4% each, the two Alphabet share classes combining for about 7%, Eli Lilly near 3%, and Tesla near 3%, and you have a portfolio whose fate is decided by roughly a dozen stocks.
Does The Active Tilt Pay Off?
This is where the math gets uncomfortable. Over the past year, FELG returned 31.4%, with shares finishing at around $42. That edged past the S&P 500’s 29.04% over the same window, which is what a growth tilt should do in a rising market.
The harder comparison is QQQ, the obvious passive alternative for an investor who wants megacap growth exposure. The NASDAQ-100 ETF returned 39.96% over the past year and 9.74% year-to-date, while FELG managed just 1.91% YTD.
The one-month rebound was also softer: 12.09% for FELG versus 15.38% for QQQ.
The enhanced overlay is producing a return profile that beats the broad market but lags the most direct passive growth competitor. For some investors, that tradeoff is acceptable in exchange for slightly broader diversification (the Russell 1000 Growth holds more names than the Nasdaq 100, including Eli Lilly and other non-Nasdaq listings). For others, paying 18 basis points to underperform QQQ is a hard sell.
What You Accept When You Buy It
- Concentration risk dressed as diversification. Owning 200-plus stocks sounds diversified, but with the top three names at 34.27% of assets, a bad quarter at NVIDIA, Apple, or Microsoft moves the whole fund.
- Rate sensitivity. Growth multiples compress when discount rates rise. With the 10-year Treasury at 4.4%, sitting in the 84th percentile of its 12-month range, the valuation tailwind that lifted these names through 2024 has thinned considerably.
- Active management that has not yet justified its fee. The enhanced strategy is supposed to add value over a full cycle. Through this cycle, it has trailed the cheapest passive alternative most growth investors would consider.
FELG fits best as a core growth holding for investors who want broader large-cap growth exposure than QQQ provides and trust Fidelity’s quant overlay to earn its 18 basis points over a full cycle; the primary risk is that megacap concentration and a 4.4% discount-rate backdrop punish growth multiples before that overlay has a chance to prove itself.
Top Gaining Stocks
Top Losing Stocks